Serimmune to Lead Discussion on Advances in Vaccine Development at Vaccine Summit 2023
Whether studying longitudinal samples, novel formulations of vaccines or boosters, pre-clinical vs. clinical vaccine responses, or vaccine vs. natural infection, SERA enables comparative, high-throughput, high-resolution analysis of epitopes to enable precision immunology, supporting the next generation of vaccine development.
- Whether studying longitudinal samples, novel formulations of vaccines or boosters, pre-clinical vs. clinical vaccine responses, or vaccine vs. natural infection, SERA enables comparative, high-throughput, high-resolution analysis of epitopes to enable precision immunology, supporting the next generation of vaccine development.
- WHO: Serimmune and Vaccine Summit 2023 will bring together experts in the field of vaccine research as well as industry leaders to address current issues facing vaccine development.
- The “New Vaccine Development” session will be led by Dr. John Shon, Chief Technology Officer, Serimmune.
- WHERE: Vaccine Summit 2023 at the Sheraton Boston Needham Hotel, Grand Ballroom.